Clinical Trials
14 trialsNCT03340506 2026-04-20
Dabrafenib and/or Trametinib Rollover Study
Novartis
Phase 4 Recruiting
NCT05110196 2026-04-07
Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.
Novartis
Phase 4 Completed
NCT07279935 2026-03-19
REVIVE
AstraZeneca
Phase 4 Not yet recruiting
NCT07469202 2026-03-13
CYTALUX Dose Extension Study
On Target Laboratories, LLC
Phase 4 Not yet recruiting
NCT05583188 2024-07-19
VIGOR
Galvanize Therapeutics, Inc.
Phase 4 Terminated
NCT02869789 2023-06-15
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Bristol-Myers Squibb
Phase 4 Completed
NCT02151149 2018-09-24
ABOUND 70+
Celgene
Phase 4 Completed
NCT02346318 2017-07-21
The Randomized Controlled Clinical Trial of Kushen Injection
Beijing Zheng Ju Medical Technology Co., Ltd.
Phase 4 Unknown
NCT01317615 2016-03-30
RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation
Novartis
Phase 4 Completed
NCT00747916 2015-07-16
Safety, Efficacy, and Side Effects Study of Interventional Cryotherapy in the Pleural Space("ICE PLS")
CSA Medical, Inc.
Phase 4 Terminated
NCT00747773 2014-01-09
CSAir 1
CSA Medical, Inc.
Phase 4 Completed
NCT00277160 2010-10-08
A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer
Amgen
Phase 4 Completed
NCT01060137 2010-02-05
Fentanyl Matrix in Lung Cancer Pain
Janssen Korea, Ltd., Korea
Phase 4 Completed
NCT00099541 2009-11-23
Non-small Cell Lung Cancer Registry
Novartis
Phase 4 Completed